3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Carcinoma, Non-Small-Cell Lung
10
Lung Neoplasms
6
Colorectal Neoplasms
3
Advanced Non-small Cell Lung Cancer With KRAS G12C Mutation
2
Venous Thromboembolism
1
Sexual Dysfunction, Physiological
1
Pancreatic Neoplasms
1
Non-small Cell Lung Cancer Metastatic
1
Non Small Lung Cancer
1
Neoplasms
1
Eunuchism
1
Erectile Dysfunction
1
Efficacy
1
Brain Neoplasms
1
Interventions
Pemetrexed
4
pembrolizumab
3
Carboplatin
3
Vinorelbine
2
Gemcitabine
2
vistusertib
1
vandetanib
1
spartalizumab
1
sotorasib
1
sintilimab
1
olaparib
1
icotinib
1
durvalumab
1
dacomitinib
1
capivasertib
1
aumolertinib
1
Radiosurgery
1
Platinum
1
MLN 8237
1
Injections
1
Immune Checkpoint Inhibitors
1
Gefitinib
1
GC Temporary Stopping
1
Erlotinib Hydrochloride
1
Drug Therapy
1
Cisplatin
1
Bevacizumab
1
AZD4547
1
AZD 8931
1
AZD 6244
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Non-small Cell Lung Cancer Metastatic
×
sotorasib
×
Clear all
NCT06127940
2023-11-13
K-SAB
Karolinska University Hospital
Phase 1
Unknown
20 enrolled